Victoza

Victoza Overdosage

liraglutide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
From clinical trials and marketed use overdoses have been reported up to 40 times (72mg) the recommended maintenance dose (72 mg). Generally the patient reported severe nausea, vomiting and diarrhoea. None of the reports included severe hypoglycaemia. All patients recovered without complications.
In the event of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in